Key Takeaways
- CRM shares have plummeted approximately 41% in 2025 and roughly 58% below their December 2024 high, starting Friday’s session at $165.94
- Guggenheim elevated its rating from Neutral to Buy, assigning a $228 target and describing the valuation as pricing in an “Armageddon” outcome
- Analyst consensus reflects a Moderate Buy recommendation, with mean price projections near $254, suggesting potential gains of 55%–57%
- First quarter results exceeded forecasts with earnings per share of $3.88 versus expectations of $3.13, while revenue reached $11.13B, marking 13.3% year-over-year growth
- The company’s artificial intelligence portfolio — featuring Agentforce and Slack-integrated agents — is now producing more than $2.3B in recurring annual revenue
Shares of Salesforce (CRM) began Friday’s trading at $165.94, reflecting a steep decline of approximately 41% since the start of the year and a drop of about 58% from the stock’s late-2024 high near $276.80. The sharp downturn has been fueled primarily by investor anxiety that emerging AI agent technology could render conventional CRM platforms irrelevant.
However, Wall Street analysts are increasingly skeptical that this narrative holds water.
This week, Guggenheim’s John DiFucci elevated his stance on CRM from Neutral to Buy, establishing a $228 price objective. His rationale centers on valuation: trading at approximately 3.7 times recurring revenue and 11 times enterprise value to next-twelve-month free cash flow, the stock appears to be discounting a perpetual 5% business contraction — a scenario DiFucci labeled as implausible.
Citigroup similarly raised its rating to Buy this week, joining a mounting wave of analysts who believe the market has overreacted.
Presently, the Street consensus reflects a Moderate Buy rating, with 28 analysts recommending Buy, 6 suggesting Hold, and 4 advising Sell.
The mean analyst price target hovers around $254, indicating potential upside of roughly 55%–57% from today’s trading levels. Citizens JMP maintains the Street’s highest target at $315.
First Quarter Performance Exceeds Expectations
Salesforce delivered Q1 financial results on May 27th that surpassed Wall Street forecasts. The enterprise software giant reported earnings per share of $3.88, beating the consensus projection of $3.13 by $0.75. Revenue totaled $11.13 billion, representing 13.3% annual growth and slightly exceeding the $11.05 billion estimate.
For fiscal year 2027, management issued full-year EPS guidance of $14.060–$14.120. Second quarter FY2027 outlook calls for EPS between $3.250–$3.270.
The stock’s 52-week trading range spans from a low of $146.32 to a high of $276.80. The 50-day moving average currently stands at $173.23, while the 200-day moving average sits at $197.71.
Artificial Intelligence Driving Tangible Revenue Growth
Contrary to fears about AI-driven disruption, Salesforce’s proprietary AI offerings are delivering substantial financial results. The company’s AI portfolio — encompassing Agentforce, Data 360, Slack-integrated AI agents, and Headless 360 APIs — is currently generating over $2.3 billion in rapidly expanding annual recurring revenue.
This figure has become a focal point for bullish analysts who argue the company is not merely defending market share — it’s actively capturing new revenue streams.
On the institutional investment front, Kepler Cheuvreux Suisse SA expanded its Salesforce holdings by 284.1% during Q1, acquiring an additional 12,568 shares to reach a total position of 16,992 shares valued at roughly $3.17 million.
Vanguard Group maintains 89.8 million shares worth approximately $23.8 billion. State Street controls 50 million shares, while institutional investors collectively hold 80.43% of outstanding shares.
Salesforce distributed a quarterly dividend of $0.44 per share on July 2nd, translating to an annualized dividend of $1.76 and a yield of approximately 1.1%.
The board of directors authorized a $25 billion stock buyback program in March, permitting the company to repurchase up to 14.1% of shares outstanding through open market transactions.
Bucking the trend, HC Wainwright downgraded CRM to a Negative rating on June 18th — representing one of just four Sell ratings currently assigned to the stock.





